AKERS BIOSCIENCES, INC. (NASDAQ:AKER) Files An 8-K Other Events
Item 8.01 Other Events.
On June 21, 2019, Akers Biosciences, Inc. (the “Company”) received a complaint, filed by Novotek Therapeutics Inc., and Novotek Pharmaceuticals Limited (collectively, “Novotek”), Beijing-based entities, in the United States District Court for the District of New Jersey, alleging, among other things, breach of contract. Novotek is seeking, among other things, damages in the amount of $1,551,562.31, plus interest, disbursements and attorneys’ fees.
The Company will contest any such complaint vigorously in the interest of its shareholders. The Company is confident in its legal position and is fully prepared to defend itself in court.